Display options
Share it on

Int J Endocrinol. 2015;2015:405157. doi: 10.1155/2015/405157. Epub 2015 May 10.

Effect of Orexin-A on Cortisol Secretion in H295R Cells via p70S6K/4EBP1 Signaling Pathway.

International journal of endocrinology

Xiaocen Chang, Yuyan Zhao, Lei Guo

Affiliations

  1. Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
  2. Department of Orthopedic Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.

PMID: 26064108 PMCID: PMC4441985 DOI: 10.1155/2015/405157

Abstract

Orexin-A is a neuropeptide that orchestrates diverse central and peripheral processes. It is now clear that orexin system plays a central role in the regulation of endocrine, paracrine, and neurocrine. It is involved in the regulation of growth hormone, adrenocorticotropic hormone, thyroid, mineralocorticoid, and cortisol secretion. These hormones may also serve as a kind of signal linking energy balance regulation, reproduction, stress response, and cardiovascular regulation. Many studies have demonstrated the ability of orexin-A to regulate adrenocortical cells through the MAPK (mitogen-activated protein kinases) pathway. The aim of our study is to investigate the effect of orexin-A on cortisol secretion via the protein 70 ribosomal protein S6 kinase-1 (p70S6K) and eukaryotic translation initiation factor 4E binding proteins (4EBP1) signaling pathway in adrenocortical cells. We reported the first evidence that orexin-A stimulated p70S6K and 4EBP1 in human H295R adrenocortical cells in a concentration and time-dependent manner. 10(-6) M orexin-A treatment for 1 hour was the most potent. Our results also indicated that p70S6K and 4EBP1 kinases participated in controlling cortisol secretion via OX1 receptor in H295R cells, which implied important role of p70S6K and 4EBP1 kinases in regulating adrenal function induced by orexin-A.

References

  1. Biochem Pharmacol. 2006 Mar 14;71(6):827-36 - PubMed
  2. Cell Mol Life Sci. 2003 Jan;60(1):72-87 - PubMed
  3. J Clin Endocrinol Metab. 2005 Jun;90(6):3544-9 - PubMed
  4. J Mol Neurosci. 2012 Jan;46(1):10-7 - PubMed
  5. Cell Signal. 2013 Dec;25(12):2413-23 - PubMed
  6. Neuroendocrinology. 2008;87(3):168-81 - PubMed
  7. J Clin Endocrinol Metab. 2001 Feb;86(2):778-82 - PubMed
  8. Endocr Relat Cancer. 2014 Aug;21(4):601-13 - PubMed
  9. Cell Cycle. 2004 Oct;3(10):1221-4 - PubMed
  10. J Pharmacol Sci. 2003 Jul;92(3):259-66 - PubMed
  11. Biochem J. 2002 Dec 1;368(Pt 2):565-72 - PubMed
  12. Int J Endocrinol. 2013;2013:854623 - PubMed
  13. Acta Physiol (Oxf). 2008 Apr;192(4):471-85 - PubMed
  14. J Endocrinol. 2009 Aug;202(2):249-61 - PubMed
  15. Nat Med. 2004 May;10(5):484-6 - PubMed
  16. Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14134-9 - PubMed
  17. Cell. 1998 Feb 20;92(4):573-85 - PubMed
  18. Mol Cell Endocrinol. 2012 Nov 25;364(1-2):101-4 - PubMed
  19. Peptides. 2001 Jan;22(1):139-42 - PubMed
  20. Histol Histopathol. 2001 Jul;16(3):713-7 - PubMed
  21. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7 - PubMed
  22. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):87-94 - PubMed
  23. Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1601-9 - PubMed
  24. Cancer Cell. 2007 Jul;12(1):9-22 - PubMed
  25. Br J Pharmacol. 2007 Jan;150(1):97-104 - PubMed
  26. J Steroid Biochem Mol Biol. 2005 Sep;96(5):423-9 - PubMed
  27. Cancer Res. 2011 May 15;71(10):3669-75 - PubMed
  28. Pharmacol Rep. 2011;63(3):717-23 - PubMed
  29. Endocrinology. 2008 Aug;149(8):4106-15 - PubMed
  30. J Mol Neurosci. 2014 Jan;52(1):48-55 - PubMed
  31. Cell Signal. 2008 Sep;20(9):1651-61 - PubMed
  32. Biochem Cell Biol. 2008 Apr;86(2):178-83 - PubMed
  33. PLoS One. 2013 Apr 23;8(4):e62399 - PubMed
  34. J Biol Chem. 2005 Feb 25;280(8):6570-9 - PubMed
  35. J Pharmacol Exp Ther. 2003 May;305(2):507-14 - PubMed

Publication Types